Currax Appoints Ed Cinca to SVP, Global Marketing & Strategic Alliance
26 Oct 2021 //
PRNEWSWIRE
Alkermes sued over death of man who overdosed after taking addiction- Vivitrol
26 Feb 2020 //
STATNEWS
FDA slaps down Alkermes for misleading Vivitrol ads
11 Dec 2019 //
ENDPTS
Nalproprion Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc.
22 Aug 2019 //
PATENT DOCS
Nalpropion Pharmaceuticals Expands Agreement with iNova Pharmaceuticals
19 Dec 2018 //
FIRSTWORDPHARMA
Enforcement Report - Week of November 14, 2018
14 Nov 2018 //
FDA
Enforcement Report - Week of August 22, 2018
22 Aug 2018 //
FDA
Elite Pharma: Eyes on Troxyca, but Pfizer blocking generic release
11 Jul 2018 //
IN-PHARMATECHNOLOGIST
With debt looming, browbeaten diet pill maker Orexigen goes bankrupt
13 Mar 2018 //
ENDPTS
FDA to boost drug therapy for addicts
26 Feb 2018 //
NWA ONLINE
Nalpropion Pharmaceuticals, Inc. Expands Agreement with iNova Pharmaceuticals
06 Feb 2018 //
GLOBENEWSWIRE
Best days are still ahead` for top opioid addiction treatment Vivitrol, CEO says
09 Jan 2018 //
CNBC
Alkermes Allegedly Fired 3 Female Employees Who Raised Concerns of Bias
29 Nov 2017 //
BIOSPACE
Alkermes touts equal efficacy of monthly Vivitrol against daily Suboxone
16 Nov 2017 //
ENDPTS
Orexigen Announces Commercialization & Distributorship Agreement with Merck KGaA
13 Nov 2017 //
PR NEWSWIRE
Alkermes balks at U.S. senator’s probe into Vivitrol marketing
08 Nov 2017 //
FIERCE PHARMA
Once-a-month shot for opioid addiction works as well as daily medication
19 Oct 2017 //
STATNEWS
Orexigen Announces Expansion distribution Agreement, Biologix FZCO for Contrave
26 Jul 2017 //
PR NEWSWIRE
Apotex Inc Generic Naltrexone Hydrochloride Receives Approval In US
26 Jul 2017 //
FDA
Vivitrol offers the fantasy of being drug-free. But that’s not most important
29 Jun 2017 //
STATNEWS
FDA Cracks Down on TV Ad for Prescription Weight Loss Drug
24 May 2017 //
RAPS
Alkermes adding 90 jobs at Ohio plant
06 Feb 2017 //
FIERCE PHARMA
Orexigen Announces Spanish Launch of Mysimba
26 Jan 2017 //
PR NEWSWIRE
Elite Provides Update on SequestOx™ New Drug Application
23 Dec 2016 //
GLOBENEWSWIRE
Orexigen Announces Commercialization & Distributorship Agreement with Consilient
08 Dec 2016 //
PR NEWSWIRE
Prisons fight opioids with $1,000 injection: Does it work?
15 Nov 2016 //
STAT
Valeant Pharma to commercialise Orexigen Therapeutics` Contrave
10 Nov 2016 //
PHARMABIZ
Alkermes Stock Climbs on Positive Test Results for Antidepressant
21 Oct 2016 //
BOSTON GLOBE
Pfizer (PFE) Release: FDA Approves TROXYCA ER
22 Aug 2016 //
BIOSPACE
Pfizer’s abuse-resistant opioid nears US market
10 Jun 2016 //
PHARMA TIMES
Compatibility of 10 different APIs in SyrSpend SF PH4 oral suspensions
29 Mar 2016 //
PHARMA-EXCIPIENTS
Orexigen Announce Submission of Contrave New Drug Application in South Korea
03 Oct 2015 //
PR NEWS WIRE
Orexigen Raises $60 Million in Sale of Common Stock to Baupost
10 Sep 2015 //
PR NEWS WIRE
Orexigen And Takeda File Lawsuit Against Actavis For Infringement Of Contrave Patents
08 Jun 2015 //
BIOSPACE
Contrave trial tussle brews between Takeda, Orexigen with Cleveland Clinic on the scene
13 May 2015 //
FIERCE PHARMA ASIA
PFIZER REPORTS FIRST-QUARTER 2015 RESULTS
28 Apr 2015 //
PFIZER
Is Europe Softening on Diet Drugs?
28 Mar 2015 //
MEDPAGE TODAY
Eisai Gets EMA Nod For Lenvima Just Weeks After FDA Approval
28 Mar 2015 //
FIERCE PHARMA
Europe Approves Orexigen`s Weight-Loss Pill Mysimba
26 Mar 2015 //
PHARMATIMES
Congress Pressures FDA to Finalize Opioid Guidance
21 Mar 2015 //
MEDPAGE TODAY
Weight-Loss Drugs Seek Acceptance From Patients and Physicians
17 Mar 2015 //
THE WALL STREET JOURNAL
What Should FDA do About the Orexigen Disclosure Episode? Take our Poll
09 Mar 2015 //
PHARMALOT
Surprise: Obesity Med Contrave Might Help CV Outcomes. Too Bad Orexigen Blabbed It
05 Mar 2015 //
FIERCE PHARMA